Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

News

The latest news, updates and announcements from the Nuffield Department of Medicine.

Study finds that Treg depletion suppresses tumour growth in Glioblastoma

A new study, co-lead by Dr Felipe Galvez-Cancino from the Centre for Immuno-Oncology, has shown that Treg cell depletion can suppress tumour growth in one of the deadliest types of cancer.

Professor Dame Sarah Gilbert, PSI, NDM

Sarah Gilbert receives Royal Society of Chemistry Honorary Fellowship

PSI Principal Investigator Professor Dame Sarah Gilbert has been made an Honorary Fellow of the Royal Society of Chemistry.

Professor Buddha Basnyat

Professor Buddha Basnyat recognised by the Nepal Health Research Council

Professor Buddha Basnyat has received the NHRC Lifetime Achievement Award for Health Research in Nepal. The Nepal Health Research Council (NHRC) recently conferred its prestigious Lifetime Achievement Award for Health Research upon Professor Basnyat at the 11th National Summit of Health and Population Scientists. This honour recognises his exceptional contributions to medical research and public health over a career spanning more than five decades.

cancer research in lab

New combination therapy developed for acute myeloid leukaemia

Researchers in the Shi group at Ludwig Cancer Research Oxford have developed a new combination therapy for acute myeloid leukaemia, showing therapeutic promise by promoting differentiation of immature blood cells.

Dr Sulochana Manandhar

Blog: Tackling newborn infection risks in Nepal

At OUCRU Nepal, microbiologist Sulochana Manandhar spent much of her early career at the lab bench, examining bacteria, fine-tuning methods, and chasing answers to scientific questions. Now, with support from the MODRA programme, she’s leading her first hospital-based study, bringing new attention to neonatal health risks in Nepal.

Woman using asthma inhaler

Study identifies direct link between inflammation and asthma attacks

An international consortium of respiratory scientists, including researchers from NDM’s Experimental Medicine Division, have shed light on the role of inflammation in asthma. Through their findings, they have provided a new way of predicting and preventing asthma attacks.

Up to £16.5 million awarded to global consortium to overcome obstacles in infectious disease research

The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC) has been awarded up to £16.5 million to build on its globally-recognised efforts to prevent illness and deaths from epidemic-prone infectious diseases.

Blog: From post-PhD uncertainty to leading international research

Dr Duong Thi Hue Kien, a Post-doc Scientist at OUCRU, has shared her experience of finishing her PhD and kickstarting her career in science. She documents the highs and the lows, as well as how she was able to move forward in her career with support from the MORU–OUCRU Discovery Research Academy.

KEMRI signs landmark partnership with Wellcome and Oxford

The Kenya Medical Research Institute (KEMRI) has officially entered into a seven-year Memorandum of Understanding (MoU) with Wellcome, a UK-based charitable foundation, and the University of Oxford. The £91 million agreement was signed at the Wellcome headquarters in London, marking a significant boost for medical research and training in Kenya.

NDM researchers appointed co-Associate Directors of Oxford Global Health

Professor Susanna Dunachie and Dr Caesar Atuire of the Centre for Tropical Medicine and Global Health have been appointed as Co-Associate Directors of the Oxford Global Health initiative.

Research team receive £5.5m in funding to transform bowel cancer care

Cancer Research UK and partners have committed £5.5 million in funding to form a world-leading research team, co-led by NDM’s Professor Simon Leedham. The team’s goal is to make personalised medicine a reality for people with bowel cancer.

BCG Challenge Study of a Novel TB Vaccine

First human trial of aerosol vaccine delivery launched

The Jenner Institute, in partnership with the Coler Lab at Seattle Children’s Research Institute (SCRI), is set to begin a new clinical trial to test tuberculosis (TB) vaccine safety and the host immune response in a first-in-man aerosol mycobacterial challenge infection model with healthy adult volunteers.

One-third of antibiotics used in Vietnam are ‘inappropriate’

Ranking 11th globally in antibiotic use, Vietnam faces a serious risk of drug resistance, and could be ‘running out of treatment options due to antibiotic resistance’.

RECOVERY trial team win NIHR Impact Prize

Co-led by PSI Director Professor Sir Peter Horby, the RECOVERY trial was defined "one of the most well-known studies supported by the NIHR with clear national and global impact.”

Oxford marks World Tuberculosis Day as vaccine trials continue

Thanks to cutting edge research at NDM's Jenner Institute and Oxford University Clinical Research Unit (OUCRU), Oxford remains at the forefront of research to develop new vaccines to protect against this devastating disease.

Lower-dose yellow fever vaccine as effective as the current standard

In a recent study, researchers at the KEMRI Wellcome Trust Research Programme in Kenya have discovered that a low-dose of the yellow fever vaccine is as effective as the current standard dose.

Dr Emilia Antonio

Prioritising research to better address high-consequence outbreaks

A new paper published in BMC Medicine analyses research prioritisation approaches for high-consequence pathogens.

‘Brain bins’ in neck lymph nodes offer clues about brain health

Scientists have found another clue about how brain health is maintained and how this might be affected by ageing and Alzheimer’s disease, according to a new paper.

New paper outlines ethical issues in clinical metagenomics

Researchers have published the first paper mapping clinical ethics questions raised by new metagenomic techniques for diagnosing disease in clinical practice.

Immune response may be harnessed to control HIV

Researchers have unveiled primary trial results that show encouraging advances in HIV treatment driven by immune-based therapies. New antibody therapies could offer alternative to current treatments.

Load More